BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38745021)

  • 21. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naive and regulatory B-cell transcription patterns guide the increased risk of papillary thyroid carcinoma in obesity.
    Yu Z; Xu Z; Li S; Tian Z; Yuan J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):118-126. PubMed ID: 38678617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodule Size Effect on Diagnostic Performance of Ultrasonography and Computed Tomography for Papillary Thyroid Carcinoma.
    Li JW; Chang C; Chen JY; Shi ZT; Chen M
    Curr Med Imaging Rev; 2019; 15(5):489-495. PubMed ID: 32008556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
    Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Based on different immune responses under the glucose metabolizing type of papillary thyroid cancer and the response to anti-PD-1 therapy.
    Xie W; Zeng Y; Hu L; Hao J; Chen Y; Yun X; Lin Q; Li H
    Front Immunol; 2022; 13():991656. PubMed ID: 36211409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
    Yin Y; Che K; Hu J; Hua H; Dong A; Wang J; Yu J; Zhang Q; Zhao S; Zhao Y; Wang P; Wang F; Wang Y; Chi J; Sun W
    Int J Oncol; 2020 May; 56(5):1284-1293. PubMed ID: 32319586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
    Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
    Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
    Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
    Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
    Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
    Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Cell Transcriptomic Analysis of Ecosystems in Papillary Thyroid Carcinoma Progression.
    Yan T; Qiu W; Weng H; Fan Y; Zhou G; Yang Z
    Front Endocrinol (Lausanne); 2021; 12():729565. PubMed ID: 34790166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
    Chen X; Jin J; Zheng L; Sheng Y; Sun J
    J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
    Gao H; Sun X; Wang H; Zheng Y
    Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
    Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
    Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
    Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
    J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
    Kim H; Na KJ; Choi JH; Ahn BC; Ahn D; Sohn JH
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1569-76. PubMed ID: 25971994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma.
    Huang Y; Chang A; Zhou W; Zhao H; Zhuo X
    Clin Exp Med; 2020 Nov; 20(4):515-525. PubMed ID: 32596748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
    Szpak-Ulczok S; Pfeifer A; Rusinek D; Oczko-Wojciechowska M; Kowalska M; Tyszkiewicz T; Cieslicka M; Handkiewicz-Junak D; Fujarewicz K; Lange D; Chmielik E; Zembala-Nozynska E; Student S; Kotecka-Blicharz A; Kluczewska-Galka A; Jarzab B; Czarniecka A; Jarzab M; Krajewska J
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma.
    Pu W; Shi X; Yu P; Zhang M; Liu Z; Tan L; Han P; Wang Y; Ji D; Gan H; Wei W; Lu Z; Qu N; Hu J; Hu X; Luo Z; Li H; Ji Q; Wang J; Zhang X; Wang YL
    Nat Commun; 2021 Oct; 12(1):6058. PubMed ID: 34663816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.